A phase II study of weekly edatrexate (10-EDAM) in metastatic melanoma. A National Cancer Institute of Canada Clinical Trials Group study (Q33494642)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase II study of weekly edatrexate (10-EDAM) in metastatic melanoma. A National Cancer Institute of Canada Clinical Trials Group study |
scientific article |
Statements
1 reference
A phase II study of weekly edatrexate (10-EDAM) in metastatic melanoma. A National Cancer Institute of Canada Clinical Trials Group study (English)
1 reference
S Verma
1 reference
I C Quirt
1 reference
E A Eisenhauer
1 reference
N A Iscoe
1 reference
V J Young
1 reference
A J Bodurtha
1 reference
J Davidson
1 reference
1 reference
Identifiers
1 reference